Search Results - "Villela‐Nogueira, C. A."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP) by Cardoso, A. C., Perez, R. M., Figueiredo‐Mendes, C., Carvalho Leite, N., Moraes‐Coelho, H. S., VillelaNogueira, C. A.

    Published in Journal of viral hepatitis (01-11-2018)
    “…Summary A novel controlled attenuation parameter (CAP) using FibroScan® has been developed for assessment of liver steatosis. The aim was to evaluate the…”
    Get full text
    Journal Article
  2. 2

    Lower levels of dehydroepiandrosterone sulfate are associated with more advanced liver fibrosis in chronic hepatitis C by Araujo Neto, J. M., Coelho, H. S. M., Chindamo, M. C., Rezende, G. F. M., Nunes Pannain, V. L., Bottino, A. M. C. F., Bruzzi Porto, L. F., Luiz, R. R., VillelaNogueira, C. A., Perez, R. M.

    Published in Journal of viral hepatitis (01-03-2018)
    “…Summary Chronic infection with the hepatitis C virus induces liver fibrosis, but it is unknown why some patients progress to advanced fibrosis while others…”
    Get full text
    Journal Article
  3. 3

    Comparison of oral fluid collection methods for the molecular detection of hepatitis B virus by Portilho, MM, Mendonça, ACF, Marques, VA, Nabuco, LC, VillelaNogueira, CA, Ivantes, CAP, Lewis‐Ximenez, LL, Lampe, E, Villar, LM

    Published in Oral diseases (01-11-2017)
    “…Background This study aims to compare the efficiency of four oral fluid collection methods (Salivette, FTA Card, spitting and DNA‐Sal) to detect HBV DNA by…”
    Get full text
    Journal Article
  4. 4

    An evaluation of different saliva collection methods for detection of antibodies against hepatitis C virus (anti-HCV) by Cruz, H. M., Marques, V. A., Villela-Nogueira, C. A., do Ó, K. M. R., Lewis-Ximenez, L. L., Lampe, E., Villar, L. M.

    Published in Journal of oral pathology & medicine (01-11-2012)
    “…J Oral Pathol Med (2012) 41: 793–800 Background:  Saliva samples can be used as an alternative fluid for against hepatitis C virus (anti‐HCV) detection owing…”
    Get full text
    Journal Article
  5. 5

    Dried blood spot samples: Optimization of commercial EIAs for hepatitis C antibody detection and stability under different storage conditions by Marques, B.L.C., Brandão, C.U., Silva, E.F., Marques, V.A., Villela-Nogueira, C.A., Do Ó, K.M.R., de Paula, M.T., Lewis-Ximenez, L.L., Lampe, E., Villar, L.M.

    Published in Journal of medical virology (01-10-2012)
    “…This study was undertaken to optimize and compare the efficiency of two commercial EIAs for anti‐HCV detection (HCV Ab Radim, Pomezzia, Italy and ETI‐AB‐HCVK‐4…”
    Get full text
    Journal Article
  6. 6

    Circulating microRNAs associated with liver fibrosis in chronic hepatitis C patients by Cabral, B.C.A., Hoffmann, L., Bottaro, T., Costa, P.F., Ramos, A.L.A., Coelho, H.S.M., Villela-Nogueira, C.A., Ürményi, T.P., Faffe, D.S., Silva, R.

    Published in Biochemistry and biophysics reports (01-12-2020)
    “…A major challenge in hepatitis C research is the detection of early potential for progressive liver disease. MicroRNAs (miRNAs) are small RNAs that regulate…”
    Get full text
    Journal Article
  7. 7

    Simultaneous detection of hepatitis c virus antigen and antibodies in dried blood spots by Brandão, C.P.U, Marques, B.L.C, Marques, V.A, Villela-Nogueira, C.A, Do Ó, K.M.R, de Paula, M.T, Lewis-Ximenez, L.L, Lampe, E, Sá Ferreira, J.A, Villar, L.M

    Published in Journal of clinical virology (01-06-2013)
    “…Abstract Background Enzyme immunoassays (EIA) designed to detect hepatitis C virus (HCV) core antigen and anti-HCV antibodies (HCV AgAb) simultaneously can…”
    Get full text
    Journal Article
  8. 8

    Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment by Leite, Nathalie C, Villela-Nogueira, Cristiane A, Cardoso, Claudia R L, Salles, Gil F

    Published in World journal of gastroenterology : WJG (14-07-2014)
    “…Non-alcoholic fatty liver disease(NAFLD)is highly prevalent in patients with diabetes mellitus and increasing evidence suggests that patients with type…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11